A nonprofit run by Anne Wojcicki, the cofounder and former CEO of 23andme, has agreed to buy the genetic testing company for ...

A nonprofit led by the co-founder of genetic testing company 23andMe has won a bid to purchase the company, which declared bankruptcy in March.

Anne Wojcicki is taking back reins of 23andMe after outbidding Regeneron. The entrepreneur's proposal offers better ...

Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...

Tax Portion Of Senate Megabill Expected Monday Text of the Senate GOP's tax package won’t be out until Monday, according to four people with knowledge of the plans. The slipped timing for text, first ...

TTAM Research Institute, a nonprofit public benefit corporation based in California and led by 23andMe co-founder and former ...

The DNA data of more than 15 million customers of DNA testing firm 23andMe is set to be returned to the control of 23andMe co ...

In today's Pharmalittle roundup, we're reading about a Sarepta setback with its Duchenne drug, the FDA workload causing a ...

TTAM Research Institute, the nonprofit led by 23andMe's former CEO Anne Wojcicki, has won back 23andMe’s core assets: its Personal Genome Service, Research Services, and telehealth subsidiary Lemonaid ...

As the lawsuit spells out, 23andMe has quite a bit of “immutable” — meaning unchanging — personal data. For anyone unfamiliar ...

TTAM Research Institute, a non-profit public benefit company also founded by Wojcicki, won the auction with a $305 million ...

The French retail bank will buy the Portuguese lender from its majority owner Lone Star in the latest cross-border deal in European banking. A chip-manufacturing spinoff could help solve some of the ...